SHZ · 300326.SZ
Shanghai Kinetic Medical Co., Ltd
CN¥6.37+CN¥0.03 (+0.47%)
Shanghai Kinetic Medical Co., Ltd’s quoted price sits in the upper half of its reported 52-week range, 13.1% below the high.
Loading market information…
SHH · 688298.SS · CNY
Stock price, dividends, earnings
Quote as of Oct 30, 2026, 07:00 AM UTC. Cached market data; not a live quote.
One-year closing-price history · CNY. Historical prices are not a forecast.
Zhejiang Orient Gene Biotech Co., Ltd’s quoted price sits in the lower half of its reported 52-week range, 41.08% below the high.
52-week range
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
THE INCOME SIDE
Zhejiang Orient Gene Biotech Co., Ltd’s forward annual dividend is CN¥1.67 per share, paid annual. The forward yield is 9.76% at the quoted price. Future payments can change.
Historical amounts are adjusted for stock splits. Understand ex-dividend and payment dates →
BEHIND THE RESULTS
Upcoming dates and analyst estimates may change. Fiscal quarters follow Zhejiang Orient Gene Biotech Co., Ltd’s reporting calendar.
THE COMPANY BEHIND THE TICKER
Zhejiang Orient Gene Biotech Co., Ltd researches and develops, produces, and sells in vitro diagnostic products worldwide. Its products include POCT instant diagnostic reagents, used for detection of infectious diseases, drugs of abuse, fertility, tumor marker, and cardiac marker detection. The company offers its products for various categories, including COVID-19 diagnosis solutions; immunological diagnosis; quantum-beads flowcytometry; instrument; dry biochemical strips; raw materials; FISH probes; animal health; biochemistry; molecular diagnosis; and quantum-beads multiplex. Zhejiang Orient Gene Biotech Co., Ltd was founded in 2005 and is based in Huzhou, China.
Latest available per-share figures in CNY. The payout ratio compares dividends with earnings.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Oct 30, 2026, 08:10 AM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
Completed calendar years and any current-year payments shown separately. Current-year totals are incomplete until all payments are made.
See annual income at the current dividend rate.
Assumes the annual dividend stays unchanged. Payments follow the company’s schedule. Excludes taxes, fees and currency changes.
HOW THE BUSINESS IS PERFORMING
Statement amounts use the company’s reporting currency and are not converted to the stock’s listing currency. K = thousand, M = million, B = billion, T = trillion. Cash-flow figures are matched by fiscal year; missing figures appear as a dash.
PUT THE NUMBERS IN CONTEXT
Current metrics alongside available historical medians. A lower multiple or higher margin alone does not establish whether a stock is a good investment.
KEEP COMPARING
CN¥6.37+CN¥0.03 (+0.47%)
Shanghai Kinetic Medical Co., Ltd’s quoted price sits in the upper half of its reported 52-week range, 13.1% below the high.
CN¥8.45-CN¥0.09 (-1.05%)
Getein Biotech, Inc’s quoted price sits in the lower half of its reported 52-week range, 26.01% below the high.
CN¥13.44-CN¥0.66 (-4.68%)
Ningbo David Medical Device Co., Ltd.’s quoted price sits in the upper half of its reported 52-week range, 20.47% below the high.
CN¥38.30-CN¥0.45 (-1.16%)
Nanjing Vishee Medical Technology Co., Ltd’s quoted price sits in the lower half of its reported 52-week range, 47.0% below the high.
CN¥4.45-CN¥0.08 (-1.77%)
Beijing Bohui Innovation Biotechnology Group Co., Ltd.’s quoted price sits in the lower half of its reported 52-week range, 48.44% below the high.
CN¥14.22+CN¥0.11 (+0.78%)
Wuhan Easy Diagnosis Biomedicine Co.,Ltd.’s quoted price sits in the lower half of its reported 52-week range, 31.86% below the high.
CN¥5.90+CN¥0.30 (+5.36%)
Beijing Leadman Biochemistry Co.,Ltd.’s quoted price sits in the lower half of its reported 52-week range, 43.32% below the high.
CN¥5.05-CN¥0.23 (-4.36%)
Shanghai Kehua Bio-engineering Co., Ltd.’s quoted price sits in the lower half of its reported 52-week range, 33.02% below the high.
